{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:52:33Z","timestamp":1791222753246,"version":"4.1.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Existing life cycle frameworks for health technologies have mainly adopted a product-oriented perspective. They treating evidence as a linear input to discrete regulatory and coverage decisions, and failing to capture the iterative, context-dependent, stakeholder-specific nature of knowledge generation needed for contemporary health-technology governance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This article introduces the Life Cycle of Health Technologies 2.0 (LC 2.0), an updated conceptual framework building on the Life Cycle of Health Technologies (2017, LC 1.0). It traces the evolution from LC 1.0 to LC 2.0, conceptualises LC 2.0 as a knowledge life cycle, and outlines illustrative use cases. LC 2.0 integrates existing conceptual approaches to explore how knowledge about a health technology develops across stakeholder groups across different processes. In line with the Health for All Policies concept, it links this knowledge life cycle to societal, system and patient needs within and beyond the health sector.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mixed-methods approach was applied comprising multi-stakeholder workshops and use-case validation across four technology types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Workshops identified revision requirements in LC 1.0 across macro, meso and micro levels, centring on structural inflexibility, implicit post-market learning and limited integration of contextual and stakeholder knowledge. The LC 2.0 framework addresses these through an infinity-loop structure with six phases and twelve subprocesses. It makes knowledge generation an explicit function at every phase and maps knowledge requirements to stakeholder roles. It also incorporates flexible, non-sequential pathways, including a cross-phase transition point (X) as governance decision point between research and development and between continued optimisation and more fundamental revision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LC 2.0 reconceives the health-technology life cycle as an iterative knowledge-generation and decision-supporting service, structuring what must be learned, by whom and when, to support appropriate technology use, needs-driven innovation and regulator-appropriate evidence generation, and to provide a shared reference framework for stakeholders inside and adjacent to healthcare and regulatory systems. This shared structure also facilitates easier exchange between different health-system contexts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1869110","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:30:24Z","timestamp":1786339824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["From product to knowledge: the life cycle of health technologies 2.0 as a framework for health system improvement"],"prefix":"10.3389","volume":"17","author":[{"given":"M.","family":"Otte","sequence":"first","affiliation":[{"name":"Innovationsinstitut f\u00fcr Gesundheit und Gesellschaft gUG (I2GG gUG)","place":["J\u00fcchen, Germany"]},{"name":"EuroScan international network e. V.","place":["Cologne, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Guti\u00e9rrez-Ibarluzea","sequence":"additional","affiliation":[{"name":"EuroScan international network e. V.","place":["Cologne, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Dauben","sequence":"additional","affiliation":[{"name":"Innovationsinstitut f\u00fcr Gesundheit und Gesellschaft gUG (I2GG gUG)","place":["J\u00fcchen, Germany"]},{"name":"EuroScan international network e. V.","place":["Cologne, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"940886","DOI":"10.3389\/fmed.2022.940886","article-title":"Outcome-based reimbursement in central-eastern Europe and middle-east","volume":"9","author":"\u00c1d\u00e1m","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B2","unstructured":"Real-world evidence\n          \n          \n          2026"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0324285","DOI":"10.1371\/journal.pone.0324285","article-title":"Evaluating the effectiveness of data governance frameworks in ensuring security and privacy of healthcare data: a quantitative analysis of ISO standards, GDPR, and HIPAA in blockchain technology","volume":"20","author":"Ahmed","year":"2025","journal-title":"PLoS One"},{"key":"B4","volume-title":"Sustainable Development Goals. SDGs Transform our World","author":"Assembly","year":"2015"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e074075corr1","DOI":"10.1136\/bmjopen-2023-074075corr1","article-title":"Correction: how does participatory research work: protocol for a realist synthesis","volume":"14","year":"2024","journal-title":"BMJ Open"},{"key":"B6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.1990.03450020087032","article-title":"The case for reassessment of health care technology: once is not enough","volume":"264","author":"Banta","year":"1990","journal-title":"Jama"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.healthpol.2015.09.009","article-title":"Health workforce governance: processes, tools and actors towards a competent workforce for integrated health services delivery","volume":"119","author":"Barbazza","year":"2015","journal-title":"Health Policy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/d41573-025-00024-y","article-title":"A new European platform for advancing regulatory science research","volume":"24","author":"Barbier","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"B9","volume-title":"EuroScan\/iHTS \u2013 BRIDGE 2026","year":"2026"},{"key":"B10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/S0266462318000508","article-title":"Ethics in health technology assessment: a systematic review","volume":"34","author":"Bellemare","year":"2018","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13012-020-01003-0","article-title":"The use of the PARIHS framework in implementation research and practice-a citation analysis of the literature","volume":"15","author":"Bergstr\u00f6m","year":"2020","journal-title":"Implement Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.banm.2024.02.002","article-title":"Rapport 24-01. L\u2019innovation en sant\u00e9: une action volontariste de l\u2019\u00c9tat face \u00e0 la complexit\u00e9 de son organisation","volume":"208","author":"Boitard","year":"2024","journal-title":"Bull. l'Acad\u00e9mie Natl. M\u00e9decine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/MLR.0000000000000778","article-title":"A multilevel approach to stakeholder engagement in the formulation of a clinical data research network","volume":"56","author":"Boyer","year":"2018","journal-title":"Med. Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.18553\/jmcp.2017.23.2.125","article-title":"Payer perspectives on patient-reported outcomes in health care decision making: oncology examples","volume":"23","author":"Brogan","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1017\/S0266462325100494","article-title":"Engaging stakeholders along health technology assessment pathways: a scoping review of international practice","volume":"41","author":"Carter","year":"2025","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B16","volume-title":"Explanation of the 2011 OCEBM Levels of Evidence","year":"2025"},{"key":"B17","first-page":"27","article-title":"A conceptual approach to validating competence frameworks","volume":"35","author":"Child","year":"2023","journal-title":"Res. Matters"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2023.1289365","article-title":"Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop","author":"Claire","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B19","volume-title":"MDIC EEM Framework","author":"Consortium","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/0272989X11426484","article-title":"An equity framework for health technology assessments","volume":"32","author":"Culyer","year":"2012","journal-title":"Med. Decis. Mak."},{"key":"B21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40290-022-00456-6","article-title":"Real-world evidence: a primer","volume":"37","author":"Dang","year":"2023","journal-title":"Pharm. Med."},{"key":"B23","first-page":"644","article-title":"OCEBM levels of evidence system","volume":"68","author":"Durieux","year":"2013","journal-title":"Rev. medicale Liege"},{"key":"B24","doi-asserted-by":"publisher","first-page":"f3011","DOI":"10.1136\/bmj.f3011","article-title":"IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages","volume":"346","author":"Ergina","year":"2013","journal-title":"Bmj"},{"key":"B25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/s12913-018-3494-y","article-title":"Knowledge translation and health technology reassessment: identifying synergy","volume":"18","author":"Esmail","year":"2018","journal-title":"BMC Health Serv. Res."},{"key":"B26","volume-title":"Patient-Centred Health Research and Innovation in the EU 2026","year":""},{"key":"B27","volume-title":"Pre-Commercial Procurement","year":""},{"key":"B28","article-title":"ICH E9 statistical principles for clinical trials - Scientific guideline","year":"1998"},{"key":"B29","unstructured":"Advanced therapy medicinal products: overview"},{"key":"B30","unstructured":"Guideline on safety and efficacy follow-up and risk management of advanced therapy medicinal products - scientific guideline 2026"},{"key":"B31","unstructured":"Follow-up of patients administered with gene therapy medicinal products - scientific guideline 2026"},{"key":"B32","volume-title":"Health Technology","year":"2025"},{"key":"B33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fphar.2019.00933","article-title":"Conceptual framework of the impact of health technology on healthcare system","volume":"10","author":"Farid","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/CEOR.S14404","article-title":"Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application","volume":"3","author":"Goeree","year":"2011","journal-title":"Clin. Outcomes Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/jebm.12018","article-title":"Understanding GRADE: an introduction","volume":"6","author":"Goldet","year":"2013","journal-title":"J. Evidence Based Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/healthcare12111057","article-title":"Clinical validation of digital healthcare solutions: state of the art, challenges and opportunities","volume":"12","author":"Gomis-Pastor","year":"2024","journal-title":"Healthc. (Basel)"},{"key":"B37","first-page":"SP200","article-title":"Healthcare technology assessment: methods, framework, and role in policy making","volume":"4","author":"Goodman","year":"1998","journal-title":"Am. J. Manag. Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10488-014-0552-6","article-title":"Approaches to mixed methods dissemination and implementation research: methods, strengths, caveats, and opportunities","volume":"42","author":"Green","year":"2015","journal-title":"Adm. Policy Ment. Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e8775","DOI":"10.2196\/jmir.8775","article-title":"Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies","volume":"19","author":"Greenhalgh","year":"2017","journal-title":"J. Medical Internet Research"},{"key":"B40","volume-title":"Making Health for all Policies: Harnessing the co-benefits of Health","author":"Greer","year":"2023"},{"key":"B41","volume-title":"Oxford Centre for Evidence Based Medicine 2011 Levels of Evidence Traduction Fran\u00e7aise","year":"2012"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2017.00014","article-title":"The life cycle of health technologies. Challenges and ways forward","volume":"8","author":"Gutierrez-Ibarluzea","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5334\/ijic.icic22090","article-title":"Better care for people with multimorbidity: needs identified in three European health systems. Initial results of the CAREMATRIX project","volume":"22","author":"Gutierrez-Ibarluzea","year":"2022","journal-title":"Int. J. Integr. Care"},{"key":"B44","article-title":"Evidenzrecherche in der Gesundheitsf\u00f6rderung (Wissensband 10, Teil 2 Kurzanleitung)","volume-title":"Fonds Gesundes \u00d6sterreich","author":"Haas","year":"2013"},{"key":"B45","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.psychres.2019.112516","article-title":"Qualitative methods in implementation research: an introduction","volume":"280","author":"Hamilton","year":"2019","journal-title":"Psychiatry Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrd4621","article-title":"Impact of scientific advice from the european medicines agency","volume":"14","author":"Hofer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B47","doi-asserted-by":"publisher","first-page":"942230","DOI":"10.3389\/fpubh.2022.942230","article-title":"A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies","volume":"10","author":"Ibargoyen-Roteta","year":"2022","journal-title":"Front. Public Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1017\/s0266462324000886","article-title":"OP25 rapid molecular tests for detecting multidrug-resistant microorganisms: an overview of systematic reviews within A living evidence project","volume":"40","author":"Imeshtari","year":"2025","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.hlpt.2022.100663","article-title":"The regulatory gap in digital health and alternative pathways to bridge it","volume":"11","author":"Iqbal","year":"2022","journal-title":"Health Policy Technol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/10430342251403439","article-title":"Long-term Follow-Up of patients receiving cell and gene therapy products","volume":"37","author":"Irinyi","year":"2026","journal-title":"Hum. Gene Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1017\/S0266462325100238","article-title":"Actions for stakeholders to develop better real-world evidence for HTA bodies\/payers decision making","volume":"41","author":"Jaksa","year":"2025","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B52","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/wcs.76","article-title":"Decision making under risk and uncertainty","volume":"1","author":"Johnson","year":"2010","journal-title":"Wiley Interdiscip. Rev. Cognitive Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1017\/s0266462302000247","article-title":"Summary report of the ECHTA\/ECAHI project","volume":"18","author":"Jonsson","year":"2002","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B54","unstructured":"Optimizing regulatory lifecycle management realize the full value of your products and portfolio\n          \n          \n            \n              Kardas\n              M.\n            \n          \n          \n          2022"},{"key":"B56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2174\/1874431101004010202","article-title":"A sociotechnical approach to evaluating the impact of ICT on clinical care environments","volume":"4","author":"Li","year":"2010","journal-title":"Open Med. Inf. J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.26633\/RPSP.2021.81","article-title":"The sustainable development goals and technological capacity","volume":"45","author":"Mayer-Foulkes","year":"2021","journal-title":"Rev. Panam. Salud P\u00fablica"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.51731\/cjht.2023.650","article-title":"Overview of health technology assessment processes for time-limited recommendations","volume":"3","author":"Mendell","year":"2023","journal-title":"Can. J. Health Technol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12961-015-0005-z","article-title":"A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework","volume":"13","author":"Moullin","year":"2015","journal-title":"Health Res. Policy Syst."},{"key":"B60","volume-title":"Challenges of Implementing Complexity in Healthcare. Healthcare Management Forum","author":"Nason","year":"2023"},{"key":"B61","volume-title":"Communities in Action: Pathways to Health Equity","year":"2017"},{"key":"B62","unstructured":"The EuroScan Toolkit V 2025 2025\n          \n          \n          2025"},{"key":"B63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12913-019-4015-3","article-title":"Context matters in implementation science: a scoping review of determinant frameworks that describe contextual determinants for implementation outcomes","volume":"19","author":"Nilsen","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"B65","volume-title":"The VALIDATE Handbook: An Approach on the Integration of Values in Doing Assessments of Health Technologies","author":"Oortwijn","year":"2022"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14737167.2024.2398482","article-title":"Value based healthcare and health technology assessment for emerging market countries: joint efforts to overcome barriers","volume":"24","author":"Otte","year":"2024","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jamia\/ocaa197","article-title":"Putting the social back into sociotechnical: case studies of co-design in digital health","volume":"28","author":"Papoutsi","year":"2021","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B73","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12874-019-0814-9","article-title":"Pragmatic trials and implementation science: grounds for divorce?","volume":"19","author":"Pawson","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1017\/S0266462324000187","article-title":"Lifecycle HTA: promising applications and a framework for implementation. An HTAi global policy forum task force report","volume":"40","author":"Pichler","year":"2024","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B75","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41698-022-00316-1","article-title":"A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada","volume":"6","author":"Regier","year":"2022","journal-title":"Npj Precis. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12955-019-1220-z","article-title":"The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis","volume":"17","author":"Rivera","year":"2019","journal-title":"Health Qual. Life Outcomes"},{"key":"B77","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1108\/JHOM-07-2020-0296","article-title":"Context counts: a qualitative study exploring the interplay between context and implementation success","author":"Rogers","year":"2021","journal-title":"J. Health Organ Manag."},{"key":"B78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41746-020-00311-5","article-title":"Health systems as venture capital investors in digital health: 2011-2019","volume":"3","author":"Safavi","year":"2020","journal-title":"NPJ Digit. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e11072","DOI":"10.2196\/11072","article-title":"Acceptance and resistance of new digital technologies in medicine: qualitative study","volume":"7","author":"Safi","year":"2018","journal-title":"JMIR Res. Protoc."},{"key":"B80","doi-asserted-by":"publisher","first-page":"20552076241299062","DOI":"10.1177\/20552076241299062","article-title":"Opportunities and barriers for reimbursement of digital therapeutics in Austria: findings from expert interviews","volume":"11","author":"Sareban","year":"2025","journal-title":"Digit. Health"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1010247","DOI":"10.3389\/fmedt.2023.1010247","article-title":"Recent advances in addressing the market failure of new antimicrobials: learnings from NICE's subscription-style payment model","volume":"5","author":"Schurer","year":"2023","journal-title":"Front. Med. Technol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13142-014-0300-1","article-title":"Network analysis of RE-AIM framework: chronology of the field and the connectivity of its contributors","volume":"5","author":"Shoup","year":"2015","journal-title":"Transl. Behav. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/jamia\/ocad122","article-title":"A lifecycle framework illustrates eight stages necessary for realizing the benefits of patient-centered clinical decision support","volume":"30","author":"Sittig","year":"2023","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B84","volume-title":"Health in all Policies and Health in All Policies and Austerity","author":"St-Pierre","year":"2016"},{"key":"B85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hec.4505","article-title":"Recommendations for developing a lifecycle, multidimensional assessment framework for Mobile medical apps","volume":"31","author":"Tarricone","year":"2022","journal-title":"Health Econ."},{"key":"B86","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/cpt.1965","article-title":"Single\u2010arm clinical trials as pivotal evidence for cancer drug approval: a retrospective cohort study of centralized European marketing authorizations between 2010 and 2019","volume":"108","author":"Tenhunen","year":"2020","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jval.2017.11.003","article-title":"Building synergy between regulatory and HTA agencies beyond processes and procedures\u2014can we effectively align the evidentiary requirements? A survey of stakeholder perceptions","volume":"21","author":"Wang","year":"2018","journal-title":"Value Health"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e81463","DOI":"10.2196\/81463","article-title":"Digital health technologies: learnings and perspectives from a patient engagement stakeholder expectations matrix study","volume":"27","author":"West","year":"2025","journal-title":"J. Med. Internet Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"101563","DOI":"10.1016\/j.lanepe.2025.101563","article-title":"Generating evidence that meets the requirements of both regulatory agencies and HTA bodies","volume":"60","author":"Wieseler","year":"2026","journal-title":"Lancet Regional Health \u2013 Eur."},{"key":"B90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/2046-4053-3-143","article-title":"Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis","volume":"3","author":"Wilson","year":"2014","journal-title":"Syst. Reviews"},{"key":"B91","doi-asserted-by":"publisher","first-page":"888404","DOI":"10.3389\/fmedt.2022.888404","article-title":"A proposal for value-based managed entry agreements in an environment of technological change and economic challenge for publicly funded healthcare systems","volume":"4","author":"Xoxi","year":"2022","journal-title":"Front. Med. Technol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12913-024-10764-z","article-title":"Design and validation of a conceptual model regarding impact of open science on healthcare research processes","volume":"24","author":"Zarghani","year":"2024","journal-title":"BMC Health Serv. Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e58616","DOI":"10.2196\/58616","article-title":"Quality assessment of digital health apps: umbrella review","volume":"26","author":"Zych","year":"2024","journal-title":"J. Med. Internet Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1869110\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:30:28Z","timestamp":1786339828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1869110\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":86,"alternative-id":["10.3389\/fphar.2026.1869110"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1869110","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1869110"}}